nodes	percent_of_prediction	percent_of_DWPC	metapath
Riluzole—ABCG2—Dactinomycin—germ cell cancer	0.227	0.364	CbGbCtD
Riluzole—ABCG2—Cisplatin—germ cell cancer	0.13	0.209	CbGbCtD
Riluzole—ABCG2—Etoposide—germ cell cancer	0.128	0.206	CbGbCtD
Riluzole—ABCG2—Methotrexate—germ cell cancer	0.0846	0.136	CbGbCtD
Riluzole—CYP1A2—Etoposide—germ cell cancer	0.0528	0.0848	CbGbCtD
Riluzole—ABCG2—Abacavir transmembrane transport—SLC22A3—germ cell cancer	0.00772	0.161	CbGpPWpGaD
Riluzole—SCN5A—Cardiac Progenitor Differentiation—ZFP42—germ cell cancer	0.00541	0.113	CbGpPWpGaD
Riluzole—ABCG2—Abacavir transport and metabolism—SLC22A3—germ cell cancer	0.00443	0.0924	CbGpPWpGaD
Riluzole—SCN5A—Cardiac Progenitor Differentiation—SOX17—germ cell cancer	0.00297	0.0618	CbGpPWpGaD
Riluzole—SCN5A—Cardiac Progenitor Differentiation—NANOG—germ cell cancer	0.00284	0.0592	CbGpPWpGaD
Riluzole—SCN5A—Cardiac Progenitor Differentiation—POU5F1—germ cell cancer	0.00274	0.057	CbGpPWpGaD
Riluzole—ABCG2—HIF-2-alpha transcription factor network—POU5F1—germ cell cancer	0.00239	0.0497	CbGpPWpGaD
Riluzole—SCN5A—Cardiac Progenitor Differentiation—SOX2—germ cell cancer	0.00152	0.0316	CbGpPWpGaD
Riluzole—SLC7A11—NRF2 pathway—SLC2A3—germ cell cancer	0.00146	0.0303	CbGpPWpGaD
Riluzole—CYP1A2—urine—germ cell cancer	0.00131	0.0854	CbGeAlD
Riluzole—SCN5A—SIDS Susceptibility Pathways—NANOG—germ cell cancer	0.0012	0.025	CbGpPWpGaD
Riluzole—SCN5A—SIDS Susceptibility Pathways—POU5F1—germ cell cancer	0.00115	0.024	CbGpPWpGaD
Riluzole—CYP1A1—Metapathway biotransformation—NAT9—germ cell cancer	0.00114	0.0237	CbGpPWpGaD
Riluzole—SLC7A11—telencephalon—germ cell cancer	0.00109	0.0709	CbGeAlD
Riluzole—CYP1A1—skin epidermis—germ cell cancer	0.00104	0.0682	CbGeAlD
Riluzole—SLC7A11—SLC-mediated transmembrane transport—SLC2A3—germ cell cancer	0.000917	0.0191	CbGpPWpGaD
Riluzole—SLC7A11—SLC-mediated transmembrane transport—SLC22A3—germ cell cancer	0.000904	0.0188	CbGpPWpGaD
Riluzole—SLC7A11—midbrain—germ cell cancer	0.000779	0.0509	CbGeAlD
Riluzole—SLC7A11—spinal cord—germ cell cancer	0.00076	0.0497	CbGeAlD
Riluzole—SLC7A11—female gonad—germ cell cancer	0.000736	0.0481	CbGeAlD
Riluzole—CYP1A2—Metapathway biotransformation—NAT9—germ cell cancer	0.000725	0.0151	CbGpPWpGaD
Riluzole—SLC7A11—Transmembrane transport of small molecules—SCNN1A—germ cell cancer	0.000713	0.0148	CbGpPWpGaD
Riluzole—SLC7A11—endocrine gland—germ cell cancer	0.000684	0.0447	CbGeAlD
Riluzole—SLC7A11—head—germ cell cancer	0.000676	0.0441	CbGeAlD
Riluzole—SLC7A11—testis—germ cell cancer	0.000653	0.0426	CbGeAlD
Riluzole—SCN5A—SIDS Susceptibility Pathways—SOX2—germ cell cancer	0.00064	0.0133	CbGpPWpGaD
Riluzole—SCN5A—Cardiac Progenitor Differentiation—KIT—germ cell cancer	0.000625	0.013	CbGpPWpGaD
Riluzole—SLC7A11—cerebellum—germ cell cancer	0.000603	0.0394	CbGeAlD
Riluzole—SCN5A—Developmental Biology—TDGF1—germ cell cancer	0.000585	0.0122	CbGpPWpGaD
Riluzole—SLC7A11—Hemostasis—CD9—germ cell cancer	0.000523	0.0109	CbGpPWpGaD
Riluzole—SCN5A—Developmental Biology—SALL4—germ cell cancer	0.000497	0.0104	CbGpPWpGaD
Riluzole—SLC7A11—brain—germ cell cancer	0.00049	0.032	CbGeAlD
Riluzole—SCN5A—Developmental Biology—NANOG—germ cell cancer	0.000477	0.00993	CbGpPWpGaD
Riluzole—SLC7A11—Transmembrane transport of small molecules—SLC2A3—germ cell cancer	0.000466	0.00971	CbGpPWpGaD
Riluzole—SLC7A11—Transmembrane transport of small molecules—SLC22A3—germ cell cancer	0.000459	0.00957	CbGpPWpGaD
Riluzole—SCN5A—Developmental Biology—POU5F1—germ cell cancer	0.000459	0.00956	CbGpPWpGaD
Riluzole—ABCG2—trigeminal ganglion—germ cell cancer	0.000455	0.0297	CbGeAlD
Riluzole—SLC7A11—SLC-mediated transmembrane transport—AVP—germ cell cancer	0.000423	0.00881	CbGpPWpGaD
Riluzole—SCN5A—head—germ cell cancer	0.000407	0.0266	CbGeAlD
Riluzole—ABCG2—Imatinib Resistance in Chronic Myeloid Leukemia—KIT—germ cell cancer	0.000407	0.00847	CbGpPWpGaD
Riluzole—SCN5A—SIDS Susceptibility Pathways—AVP—germ cell cancer	0.000377	0.00786	CbGpPWpGaD
Riluzole—Arthralgia—Ifosfamide—germ cell cancer	0.000377	0.0012	CcSEcCtD
Riluzole—Flatulence—Cisplatin—germ cell cancer	0.000376	0.0012	CcSEcCtD
Riluzole—Anorexia—Dactinomycin—germ cell cancer	0.000376	0.0012	CcSEcCtD
Riluzole—Eye disorder—Etoposide—germ cell cancer	0.000375	0.0012	CcSEcCtD
Riluzole—Unspecified disorder of skin and subcutaneous tissue—Ifosfamide—germ cell cancer	0.000374	0.00119	CcSEcCtD
Riluzole—Cardiac disorder—Etoposide—germ cell cancer	0.000373	0.00119	CcSEcCtD
Riluzole—Discomfort—Ifosfamide—germ cell cancer	0.000372	0.00119	CcSEcCtD
Riluzole—Hypersensitivity—Vinblastine—germ cell cancer	0.000369	0.00117	CcSEcCtD
Riluzole—Dermatitis exfoliative—Methotrexate—germ cell cancer	0.000369	0.00117	CcSEcCtD
Riluzole—Decreased appetite—Bleomycin—germ cell cancer	0.000368	0.00117	CcSEcCtD
Riluzole—Muscle spasms—Cisplatin—germ cell cancer	0.000367	0.00117	CcSEcCtD
Riluzole—Angiopathy—Etoposide—germ cell cancer	0.000364	0.00116	CcSEcCtD
Riluzole—Confusional state—Ifosfamide—germ cell cancer	0.000364	0.00116	CcSEcCtD
Riluzole—Immune system disorder—Etoposide—germ cell cancer	0.000363	0.00116	CcSEcCtD
Riluzole—Mediastinal disorder—Etoposide—germ cell cancer	0.000362	0.00115	CcSEcCtD
Riluzole—Pain—Bleomycin—germ cell cancer	0.000362	0.00115	CcSEcCtD
Riluzole—Anaphylactic shock—Ifosfamide—germ cell cancer	0.000361	0.00115	CcSEcCtD
Riluzole—Oedema—Ifosfamide—germ cell cancer	0.000361	0.00115	CcSEcCtD
Riluzole—SCN5A—Developmental Biology—KLF4—germ cell cancer	0.000361	0.00753	CbGpPWpGaD
Riluzole—Chills—Etoposide—germ cell cancer	0.00036	0.00115	CcSEcCtD
Riluzole—Anaphylactoid reaction—Methotrexate—germ cell cancer	0.000359	0.00114	CcSEcCtD
Riluzole—Musculoskeletal discomfort—Dactinomycin—germ cell cancer	0.000359	0.00114	CcSEcCtD
Riluzole—Asthenia—Vinblastine—germ cell cancer	0.000359	0.00114	CcSEcCtD
Riluzole—Infection—Ifosfamide—germ cell cancer	0.000359	0.00114	CcSEcCtD
Riluzole—Tremor—Cisplatin—germ cell cancer	0.000358	0.00114	CcSEcCtD
Riluzole—ABCG2—telencephalon—germ cell cancer	0.000357	0.0233	CbGeAlD
Riluzole—Alopecia—Etoposide—germ cell cancer	0.000355	0.00113	CcSEcCtD
Riluzole—Nervous system disorder—Ifosfamide—germ cell cancer	0.000354	0.00113	CcSEcCtD
Riluzole—Ill-defined disorder—Cisplatin—germ cell cancer	0.000354	0.00113	CcSEcCtD
Riluzole—Thrombocytopenia—Ifosfamide—germ cell cancer	0.000354	0.00113	CcSEcCtD
Riluzole—Anaemia—Cisplatin—germ cell cancer	0.000353	0.00112	CcSEcCtD
Riluzole—Skin disorder—Ifosfamide—germ cell cancer	0.000351	0.00112	CcSEcCtD
Riluzole—Hyperhidrosis—Ifosfamide—germ cell cancer	0.000349	0.00111	CcSEcCtD
Riluzole—Feeling abnormal—Bleomycin—germ cell cancer	0.000348	0.00111	CcSEcCtD
Riluzole—Osteoarthritis—Methotrexate—germ cell cancer	0.000348	0.00111	CcSEcCtD
Riluzole—Anorexia—Ifosfamide—germ cell cancer	0.000344	0.0011	CcSEcCtD
Riluzole—Malaise—Cisplatin—germ cell cancer	0.000344	0.0011	CcSEcCtD
Riluzole—Decreased appetite—Dactinomycin—germ cell cancer	0.000343	0.00109	CcSEcCtD
Riluzole—Diarrhoea—Vinblastine—germ cell cancer	0.000342	0.00109	CcSEcCtD
Riluzole—Dysgeusia—Etoposide—germ cell cancer	0.000342	0.00109	CcSEcCtD
Riluzole—Leukopenia—Cisplatin—germ cell cancer	0.000342	0.00109	CcSEcCtD
Riluzole—Fatigue—Dactinomycin—germ cell cancer	0.00034	0.00108	CcSEcCtD
Riluzole—ABCG2—decidua—germ cell cancer	0.000339	0.0221	CbGeAlD
Riluzole—Back pain—Etoposide—germ cell cancer	0.000338	0.00108	CcSEcCtD
Riluzole—Hypotension—Ifosfamide—germ cell cancer	0.000338	0.00108	CcSEcCtD
Riluzole—Pain—Dactinomycin—germ cell cancer	0.000337	0.00107	CcSEcCtD
Riluzole—Muscle spasms—Etoposide—germ cell cancer	0.000336	0.00107	CcSEcCtD
Riluzole—Urticaria—Bleomycin—germ cell cancer	0.000336	0.00107	CcSEcCtD
Riluzole—Body temperature increased—Bleomycin—germ cell cancer	0.000334	0.00106	CcSEcCtD
Riluzole—Dizziness—Vinblastine—germ cell cancer	0.000331	0.00105	CcSEcCtD
Riluzole—Convulsion—Cisplatin—germ cell cancer	0.000331	0.00105	CcSEcCtD
Riluzole—Mood swings—Methotrexate—germ cell cancer	0.000329	0.00105	CcSEcCtD
Riluzole—Musculoskeletal discomfort—Ifosfamide—germ cell cancer	0.000329	0.00105	CcSEcCtD
Riluzole—Ataxia—Methotrexate—germ cell cancer	0.000327	0.00104	CcSEcCtD
Riluzole—Myalgia—Cisplatin—germ cell cancer	0.000325	0.00104	CcSEcCtD
Riluzole—Feeling abnormal—Dactinomycin—germ cell cancer	0.000325	0.00104	CcSEcCtD
Riluzole—Paraesthesia—Ifosfamide—germ cell cancer	0.000324	0.00103	CcSEcCtD
Riluzole—Ill-defined disorder—Etoposide—germ cell cancer	0.000324	0.00103	CcSEcCtD
Riluzole—Anxiety—Cisplatin—germ cell cancer	0.000324	0.00103	CcSEcCtD
Riluzole—CYP1A1—skin of body—germ cell cancer	0.000324	0.0211	CbGeAlD
Riluzole—Anaemia—Etoposide—germ cell cancer	0.000323	0.00103	CcSEcCtD
Riluzole—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—germ cell cancer	0.000323	0.00103	CcSEcCtD
Riluzole—Gastrointestinal pain—Dactinomycin—germ cell cancer	0.000322	0.00103	CcSEcCtD
Riluzole—Dyspnoea—Ifosfamide—germ cell cancer	0.000322	0.00103	CcSEcCtD
Riluzole—Somnolence—Ifosfamide—germ cell cancer	0.000321	0.00102	CcSEcCtD
Riluzole—Liver function test abnormal—Methotrexate—germ cell cancer	0.000321	0.00102	CcSEcCtD
Riluzole—Discomfort—Cisplatin—germ cell cancer	0.000321	0.00102	CcSEcCtD
Riluzole—Vomiting—Vinblastine—germ cell cancer	0.000318	0.00101	CcSEcCtD
Riluzole—Malaise—Etoposide—germ cell cancer	0.000315	0.001	CcSEcCtD
Riluzole—Breast disorder—Methotrexate—germ cell cancer	0.000314	0.001	CcSEcCtD
Riluzole—Vertigo—Etoposide—germ cell cancer	0.000314	0.001	CcSEcCtD
Riluzole—Decreased appetite—Ifosfamide—germ cell cancer	0.000314	0.001	CcSEcCtD
Riluzole—Headache—Vinblastine—germ cell cancer	0.000314	0.000999	CcSEcCtD
Riluzole—Leukopenia—Etoposide—germ cell cancer	0.000313	0.000997	CcSEcCtD
Riluzole—Gastrointestinal disorder—Ifosfamide—germ cell cancer	0.000312	0.000994	CcSEcCtD
Riluzole—Body temperature increased—Dactinomycin—germ cell cancer	0.000312	0.000993	CcSEcCtD
Riluzole—Abdominal pain—Dactinomycin—germ cell cancer	0.000312	0.000993	CcSEcCtD
Riluzole—Fatigue—Ifosfamide—germ cell cancer	0.000312	0.000992	CcSEcCtD
Riluzole—Oedema—Cisplatin—germ cell cancer	0.000311	0.000992	CcSEcCtD
Riluzole—Anaphylactic shock—Cisplatin—germ cell cancer	0.000311	0.000992	CcSEcCtD
Riluzole—Hypersensitivity—Bleomycin—germ cell cancer	0.000311	0.000992	CcSEcCtD
Riluzole—Infection—Cisplatin—germ cell cancer	0.000309	0.000986	CcSEcCtD
Riluzole—Pain—Ifosfamide—germ cell cancer	0.000309	0.000984	CcSEcCtD
Riluzole—Constipation—Ifosfamide—germ cell cancer	0.000309	0.000984	CcSEcCtD
Riluzole—Loss of consciousness—Etoposide—germ cell cancer	0.000307	0.000979	CcSEcCtD
Riluzole—Nervous system disorder—Cisplatin—germ cell cancer	0.000305	0.000973	CcSEcCtD
Riluzole—Cough—Etoposide—germ cell cancer	0.000305	0.000972	CcSEcCtD
Riluzole—Thrombocytopenia—Cisplatin—germ cell cancer	0.000305	0.000972	CcSEcCtD
Riluzole—Tachycardia—Cisplatin—germ cell cancer	0.000304	0.000969	CcSEcCtD
Riluzole—Asthenia—Bleomycin—germ cell cancer	0.000303	0.000966	CcSEcCtD
Riluzole—Convulsion—Etoposide—germ cell cancer	0.000303	0.000965	CcSEcCtD
Riluzole—Skin disorder—Cisplatin—germ cell cancer	0.000303	0.000964	CcSEcCtD
Riluzole—Hypertension—Etoposide—germ cell cancer	0.000302	0.000962	CcSEcCtD
Riluzole—Hyperhidrosis—Cisplatin—germ cell cancer	0.000301	0.000959	CcSEcCtD
Riluzole—Asthma—Methotrexate—germ cell cancer	0.000301	0.000958	CcSEcCtD
Riluzole—Pruritus—Bleomycin—germ cell cancer	0.000299	0.000953	CcSEcCtD
Riluzole—Feeling abnormal—Ifosfamide—germ cell cancer	0.000298	0.000949	CcSEcCtD
Riluzole—Chest pain—Etoposide—germ cell cancer	0.000298	0.000948	CcSEcCtD
Riluzole—Nausea—Vinblastine—germ cell cancer	0.000297	0.000947	CcSEcCtD
Riluzole—Anorexia—Cisplatin—germ cell cancer	0.000297	0.000946	CcSEcCtD
Riluzole—ABCG2—uterus—germ cell cancer	0.000296	0.0193	CbGeAlD
Riluzole—Unspecified disorder of skin and subcutaneous tissue—Etoposide—germ cell cancer	0.000296	0.000942	CcSEcCtD
Riluzole—Gastrointestinal pain—Ifosfamide—germ cell cancer	0.000295	0.000941	CcSEcCtD
Riluzole—SCN5A—brain—germ cell cancer	0.000295	0.0193	CbGeAlD
Riluzole—Pancreatitis—Methotrexate—germ cell cancer	0.000295	0.000939	CcSEcCtD
Riluzole—Discomfort—Etoposide—germ cell cancer	0.000294	0.000937	CcSEcCtD
Riluzole—Hypotension—Cisplatin—germ cell cancer	0.000291	0.000927	CcSEcCtD
Riluzole—ABCG2—pituitary gland—germ cell cancer	0.000291	0.019	CbGeAlD
Riluzole—Hypersensitivity—Dactinomycin—germ cell cancer	0.00029	0.000925	CcSEcCtD
Riluzole—Abdominal discomfort—Methotrexate—germ cell cancer	0.000288	0.000918	CcSEcCtD
Riluzole—Confusional state—Etoposide—germ cell cancer	0.000288	0.000917	CcSEcCtD
Riluzole—Urticaria—Ifosfamide—germ cell cancer	0.000287	0.000914	CcSEcCtD
Riluzole—Abdominal pain—Ifosfamide—germ cell cancer	0.000286	0.00091	CcSEcCtD
Riluzole—Body temperature increased—Ifosfamide—germ cell cancer	0.000286	0.00091	CcSEcCtD
Riluzole—Pancytopenia—Methotrexate—germ cell cancer	0.000285	0.000909	CcSEcCtD
Riluzole—Anaphylactic shock—Etoposide—germ cell cancer	0.000285	0.000909	CcSEcCtD
Riluzole—Musculoskeletal discomfort—Cisplatin—germ cell cancer	0.000284	0.000904	CcSEcCtD
Riluzole—Infection—Etoposide—germ cell cancer	0.000283	0.000903	CcSEcCtD
Riluzole—Asthenia—Dactinomycin—germ cell cancer	0.000283	0.000901	CcSEcCtD
Riluzole—CYP1A1—uterus—germ cell cancer	0.000281	0.0184	CbGeAlD
Riluzole—Dysuria—Methotrexate—germ cell cancer	0.000281	0.000895	CcSEcCtD
Riluzole—Neutropenia—Methotrexate—germ cell cancer	0.000281	0.000895	CcSEcCtD
Riluzole—ABCG2—medulla oblongata—germ cell cancer	0.000281	0.0183	CbGeAlD
Riluzole—Paraesthesia—Cisplatin—germ cell cancer	0.00028	0.000891	CcSEcCtD
Riluzole—Thrombocytopenia—Etoposide—germ cell cancer	0.000279	0.00089	CcSEcCtD
Riluzole—Tachycardia—Etoposide—germ cell cancer	0.000279	0.000887	CcSEcCtD
Riluzole—Dyspnoea—Cisplatin—germ cell cancer	0.000278	0.000885	CcSEcCtD
Riluzole—Skin disorder—Etoposide—germ cell cancer	0.000277	0.000883	CcSEcCtD
Riluzole—Erectile dysfunction—Methotrexate—germ cell cancer	0.000277	0.000882	CcSEcCtD
Riluzole—SLC7A11—Cell surface interactions at the vascular wall—HRAS—germ cell cancer	0.000276	0.00576	CbGpPWpGaD
Riluzole—Hyperhidrosis—Etoposide—germ cell cancer	0.000276	0.000879	CcSEcCtD
Riluzole—Photosensitivity reaction—Methotrexate—germ cell cancer	0.000274	0.000874	CcSEcCtD
Riluzole—Anorexia—Etoposide—germ cell cancer	0.000272	0.000867	CcSEcCtD
Riluzole—Decreased appetite—Cisplatin—germ cell cancer	0.000271	0.000863	CcSEcCtD
Riluzole—Diarrhoea—Dactinomycin—germ cell cancer	0.00027	0.000859	CcSEcCtD
Riluzole—Pneumonia—Methotrexate—germ cell cancer	0.00027	0.000859	CcSEcCtD
Riluzole—Gastrointestinal disorder—Cisplatin—germ cell cancer	0.000269	0.000857	CcSEcCtD
Riluzole—Vomiting—Bleomycin—germ cell cancer	0.000269	0.000856	CcSEcCtD
Riluzole—Infestation NOS—Methotrexate—germ cell cancer	0.000268	0.000854	CcSEcCtD
Riluzole—Infestation—Methotrexate—germ cell cancer	0.000268	0.000854	CcSEcCtD
Riluzole—Depression—Methotrexate—germ cell cancer	0.000267	0.000851	CcSEcCtD
Riluzole—Hypotension—Etoposide—germ cell cancer	0.000267	0.00085	CcSEcCtD
Riluzole—Rash—Bleomycin—germ cell cancer	0.000267	0.000849	CcSEcCtD
Riluzole—Pain—Cisplatin—germ cell cancer	0.000266	0.000849	CcSEcCtD
Riluzole—Dermatitis—Bleomycin—germ cell cancer	0.000266	0.000848	CcSEcCtD
Riluzole—Hypersensitivity—Ifosfamide—germ cell cancer	0.000266	0.000848	CcSEcCtD
Riluzole—Stomatitis—Methotrexate—germ cell cancer	0.000261	0.000832	CcSEcCtD
Riluzole—ABCG2—adrenal gland—germ cell cancer	0.00026	0.017	CbGeAlD
Riluzole—Asthenia—Ifosfamide—germ cell cancer	0.000259	0.000826	CcSEcCtD
Riluzole—ABCG2—Transmembrane transport of small molecules—SCNN1A—germ cell cancer	0.000258	0.00538	CbGpPWpGaD
Riluzole—Sweating—Methotrexate—germ cell cancer	0.000257	0.000819	CcSEcCtD
Riluzole—Feeling abnormal—Cisplatin—germ cell cancer	0.000257	0.000818	CcSEcCtD
Riluzole—ABCG2—midbrain—germ cell cancer	0.000257	0.0168	CbGeAlD
Riluzole—Paraesthesia—Etoposide—germ cell cancer	0.000256	0.000816	CcSEcCtD
Riluzole—Pruritus—Ifosfamide—germ cell cancer	0.000256	0.000814	CcSEcCtD
Riluzole—Haematuria—Methotrexate—germ cell cancer	0.000256	0.000814	CcSEcCtD
Riluzole—SCN5A—Developmental Biology—SOX2—germ cell cancer	0.000255	0.0053	CbGpPWpGaD
Riluzole—Dyspnoea—Etoposide—germ cell cancer	0.000254	0.000811	CcSEcCtD
Riluzole—Somnolence—Etoposide—germ cell cancer	0.000254	0.000808	CcSEcCtD
Riluzole—Hepatobiliary disease—Methotrexate—germ cell cancer	0.000253	0.000808	CcSEcCtD
Riluzole—Epistaxis—Methotrexate—germ cell cancer	0.000253	0.000805	CcSEcCtD
Riluzole—ABCG2—Fluoropyrimidine Activity—TP53—germ cell cancer	0.000252	0.00525	CbGpPWpGaD
Riluzole—ABCG2—bone marrow—germ cell cancer	0.000251	0.0164	CbGeAlD
Riluzole—Nausea—Bleomycin—germ cell cancer	0.000251	0.0008	CcSEcCtD
Riluzole—Vomiting—Dactinomycin—germ cell cancer	0.000251	0.000799	CcSEcCtD
Riluzole—ABCG2—spinal cord—germ cell cancer	0.00025	0.0164	CbGeAlD
Riluzole—Agranulocytosis—Methotrexate—germ cell cancer	0.00025	0.000797	CcSEcCtD
Riluzole—Rash—Dactinomycin—germ cell cancer	0.000249	0.000792	CcSEcCtD
Riluzole—Decreased appetite—Etoposide—germ cell cancer	0.000248	0.00079	CcSEcCtD
Riluzole—Diarrhoea—Ifosfamide—germ cell cancer	0.000247	0.000788	CcSEcCtD
Riluzole—Gastrointestinal disorder—Etoposide—germ cell cancer	0.000246	0.000785	CcSEcCtD
Riluzole—Body temperature increased—Cisplatin—germ cell cancer	0.000246	0.000784	CcSEcCtD
Riluzole—Fatigue—Etoposide—germ cell cancer	0.000246	0.000784	CcSEcCtD
Riluzole—Pain—Etoposide—germ cell cancer	0.000244	0.000777	CcSEcCtD
Riluzole—Constipation—Etoposide—germ cell cancer	0.000244	0.000777	CcSEcCtD
Riluzole—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—CRABP1—germ cell cancer	0.000242	0.00505	CbGpPWpGaD
Riluzole—ABCG2—female gonad—germ cell cancer	0.000242	0.0158	CbGeAlD
Riluzole—Haemoglobin—Methotrexate—germ cell cancer	0.000242	0.00077	CcSEcCtD
Riluzole—Haemorrhage—Methotrexate—germ cell cancer	0.000241	0.000766	CcSEcCtD
Riluzole—Hepatitis—Methotrexate—germ cell cancer	0.000241	0.000766	CcSEcCtD
Riluzole—Dizziness—Ifosfamide—germ cell cancer	0.000239	0.000761	CcSEcCtD
Riluzole—Pharyngitis—Methotrexate—germ cell cancer	0.000239	0.000761	CcSEcCtD
Riluzole—Urinary tract disorder—Methotrexate—germ cell cancer	0.000238	0.000757	CcSEcCtD
Riluzole—Urethral disorder—Methotrexate—germ cell cancer	0.000236	0.000751	CcSEcCtD
Riluzole—Feeling abnormal—Etoposide—germ cell cancer	0.000235	0.000749	CcSEcCtD
Riluzole—Nausea—Dactinomycin—germ cell cancer	0.000234	0.000746	CcSEcCtD
Riluzole—Gastrointestinal pain—Etoposide—germ cell cancer	0.000233	0.000743	CcSEcCtD
Riluzole—CYP1A1—female gonad—germ cell cancer	0.00023	0.015	CbGeAlD
Riluzole—Vomiting—Ifosfamide—germ cell cancer	0.00023	0.000732	CcSEcCtD
Riluzole—Hypersensitivity—Cisplatin—germ cell cancer	0.000229	0.000731	CcSEcCtD
Riluzole—Rash—Ifosfamide—germ cell cancer	0.000228	0.000726	CcSEcCtD
Riluzole—Dermatitis—Ifosfamide—germ cell cancer	0.000228	0.000725	CcSEcCtD
Riluzole—Erythema multiforme—Methotrexate—germ cell cancer	0.000227	0.000725	CcSEcCtD
Riluzole—Urticaria—Etoposide—germ cell cancer	0.000227	0.000722	CcSEcCtD
Riluzole—Abdominal pain—Etoposide—germ cell cancer	0.000226	0.000719	CcSEcCtD
Riluzole—Body temperature increased—Etoposide—germ cell cancer	0.000226	0.000719	CcSEcCtD
Riluzole—Eye disorder—Methotrexate—germ cell cancer	0.000225	0.000716	CcSEcCtD
Riluzole—ABCG2—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—germ cell cancer	0.000224	0.00466	CbGpPWpGaD
Riluzole—Asthenia—Cisplatin—germ cell cancer	0.000223	0.000712	CcSEcCtD
Riluzole—Cardiac disorder—Methotrexate—germ cell cancer	0.000223	0.000711	CcSEcCtD
Riluzole—Angiopathy—Methotrexate—germ cell cancer	0.000218	0.000695	CcSEcCtD
Riluzole—Immune system disorder—Methotrexate—germ cell cancer	0.000217	0.000692	CcSEcCtD
Riluzole—CYP1A2—endocrine gland—germ cell cancer	0.000217	0.0142	CbGeAlD
Riluzole—Mediastinal disorder—Methotrexate—germ cell cancer	0.000217	0.000691	CcSEcCtD
Riluzole—Chills—Methotrexate—germ cell cancer	0.000216	0.000688	CcSEcCtD
Riluzole—SLC7A11—Transmembrane transport of small molecules—AVP—germ cell cancer	0.000215	0.00448	CbGpPWpGaD
Riluzole—ABCG2—testis—germ cell cancer	0.000215	0.014	CbGeAlD
Riluzole—Nausea—Ifosfamide—germ cell cancer	0.000215	0.000684	CcSEcCtD
Riluzole—CYP1A1—endocrine gland—germ cell cancer	0.000214	0.014	CbGeAlD
Riluzole—Diarrhoea—Cisplatin—germ cell cancer	0.000213	0.000679	CcSEcCtD
Riluzole—Alopecia—Methotrexate—germ cell cancer	0.000213	0.000677	CcSEcCtD
Riluzole—CYP1A1—head—germ cell cancer	0.000211	0.0138	CbGeAlD
Riluzole—Mental disorder—Methotrexate—germ cell cancer	0.000211	0.000672	CcSEcCtD
Riluzole—Hypersensitivity—Etoposide—germ cell cancer	0.00021	0.00067	CcSEcCtD
Riluzole—Malnutrition—Methotrexate—germ cell cancer	0.000209	0.000667	CcSEcCtD
Riluzole—Dysgeusia—Methotrexate—germ cell cancer	0.000205	0.000653	CcSEcCtD
Riluzole—Asthenia—Etoposide—germ cell cancer	0.000205	0.000652	CcSEcCtD
Riluzole—Back pain—Methotrexate—germ cell cancer	0.000203	0.000645	CcSEcCtD
Riluzole—Pruritus—Etoposide—germ cell cancer	0.000202	0.000643	CcSEcCtD
Riluzole—ABCG2—cerebellum—germ cell cancer	0.000198	0.013	CbGeAlD
Riluzole—Vomiting—Cisplatin—germ cell cancer	0.000198	0.000631	CcSEcCtD
Riluzole—Rash—Cisplatin—germ cell cancer	0.000196	0.000626	CcSEcCtD
Riluzole—Dermatitis—Cisplatin—germ cell cancer	0.000196	0.000625	CcSEcCtD
Riluzole—Diarrhoea—Etoposide—germ cell cancer	0.000195	0.000622	CcSEcCtD
Riluzole—Ill-defined disorder—Methotrexate—germ cell cancer	0.000194	0.000619	CcSEcCtD
Riluzole—Anaemia—Methotrexate—germ cell cancer	0.000194	0.000617	CcSEcCtD
Riluzole—Malaise—Methotrexate—germ cell cancer	0.000189	0.000602	CcSEcCtD
Riluzole—Dizziness—Etoposide—germ cell cancer	0.000189	0.000601	CcSEcCtD
Riluzole—Vertigo—Methotrexate—germ cell cancer	0.000188	0.000599	CcSEcCtD
Riluzole—Leukopenia—Methotrexate—germ cell cancer	0.000187	0.000597	CcSEcCtD
Riluzole—Nausea—Cisplatin—germ cell cancer	0.000185	0.000589	CcSEcCtD
Riluzole—Cough—Methotrexate—germ cell cancer	0.000183	0.000582	CcSEcCtD
Riluzole—Convulsion—Methotrexate—germ cell cancer	0.000181	0.000578	CcSEcCtD
Riluzole—Vomiting—Etoposide—germ cell cancer	0.000181	0.000578	CcSEcCtD
Riluzole—Rash—Etoposide—germ cell cancer	0.00018	0.000573	CcSEcCtD
Riluzole—Dermatitis—Etoposide—germ cell cancer	0.00018	0.000573	CcSEcCtD
Riluzole—Headache—Etoposide—germ cell cancer	0.000179	0.00057	CcSEcCtD
Riluzole—Chest pain—Methotrexate—germ cell cancer	0.000178	0.000568	CcSEcCtD
Riluzole—Myalgia—Methotrexate—germ cell cancer	0.000178	0.000568	CcSEcCtD
Riluzole—Arthralgia—Methotrexate—germ cell cancer	0.000178	0.000568	CcSEcCtD
Riluzole—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—germ cell cancer	0.000177	0.000564	CcSEcCtD
Riluzole—Discomfort—Methotrexate—germ cell cancer	0.000176	0.000561	CcSEcCtD
Riluzole—Confusional state—Methotrexate—germ cell cancer	0.000172	0.000549	CcSEcCtD
Riluzole—Anaphylactic shock—Methotrexate—germ cell cancer	0.000171	0.000545	CcSEcCtD
Riluzole—Infection—Methotrexate—germ cell cancer	0.00017	0.000541	CcSEcCtD
Riluzole—Nausea—Etoposide—germ cell cancer	0.00017	0.00054	CcSEcCtD
Riluzole—ABCG2—Transmembrane transport of small molecules—SLC2A3—germ cell cancer	0.000169	0.00352	CbGpPWpGaD
Riluzole—Nervous system disorder—Methotrexate—germ cell cancer	0.000168	0.000534	CcSEcCtD
Riluzole—Thrombocytopenia—Methotrexate—germ cell cancer	0.000167	0.000533	CcSEcCtD
Riluzole—ABCG2—Transmembrane transport of small molecules—SLC22A3—germ cell cancer	0.000166	0.00346	CbGpPWpGaD
Riluzole—Skin disorder—Methotrexate—germ cell cancer	0.000166	0.000529	CcSEcCtD
Riluzole—Hyperhidrosis—Methotrexate—germ cell cancer	0.000165	0.000526	CcSEcCtD
Riluzole—Anorexia—Methotrexate—germ cell cancer	0.000163	0.000519	CcSEcCtD
Riluzole—ABCG2—brain—germ cell cancer	0.000161	0.0105	CbGeAlD
Riluzole—Hypotension—Methotrexate—germ cell cancer	0.00016	0.000509	CcSEcCtD
Riluzole—CYP1A1—Aryl Hydrocarbon Receptor—MYC—germ cell cancer	0.000159	0.00332	CbGpPWpGaD
Riluzole—ABCG2—lymph node—germ cell cancer	0.000156	0.0102	CbGeAlD
Riluzole—Musculoskeletal discomfort—Methotrexate—germ cell cancer	0.000156	0.000496	CcSEcCtD
Riluzole—Insomnia—Methotrexate—germ cell cancer	0.000155	0.000493	CcSEcCtD
Riluzole—Paraesthesia—Methotrexate—germ cell cancer	0.000153	0.000489	CcSEcCtD
Riluzole—CYP1A1—brain—germ cell cancer	0.000153	0.01	CbGeAlD
Riluzole—Dyspnoea—Methotrexate—germ cell cancer	0.000152	0.000485	CcSEcCtD
Riluzole—Somnolence—Methotrexate—germ cell cancer	0.000152	0.000484	CcSEcCtD
Riluzole—Dyspepsia—Methotrexate—germ cell cancer	0.00015	0.000479	CcSEcCtD
Riluzole—Decreased appetite—Methotrexate—germ cell cancer	0.000149	0.000473	CcSEcCtD
Riluzole—CYP1A1—lymph node—germ cell cancer	0.000148	0.00966	CbGeAlD
Riluzole—Gastrointestinal disorder—Methotrexate—germ cell cancer	0.000148	0.00047	CcSEcCtD
Riluzole—Fatigue—Methotrexate—germ cell cancer	0.000147	0.000469	CcSEcCtD
Riluzole—Pain—Methotrexate—germ cell cancer	0.000146	0.000466	CcSEcCtD
Riluzole—Feeling abnormal—Methotrexate—germ cell cancer	0.000141	0.000449	CcSEcCtD
Riluzole—Gastrointestinal pain—Methotrexate—germ cell cancer	0.00014	0.000445	CcSEcCtD
Riluzole—Urticaria—Methotrexate—germ cell cancer	0.000136	0.000433	CcSEcCtD
Riluzole—Body temperature increased—Methotrexate—germ cell cancer	0.000135	0.00043	CcSEcCtD
Riluzole—Abdominal pain—Methotrexate—germ cell cancer	0.000135	0.00043	CcSEcCtD
Riluzole—Hypersensitivity—Methotrexate—germ cell cancer	0.000126	0.000401	CcSEcCtD
Riluzole—CYP1A1—Aryl Hydrocarbon Receptor—HRAS—germ cell cancer	0.000125	0.00261	CbGpPWpGaD
Riluzole—Asthenia—Methotrexate—germ cell cancer	0.000123	0.000391	CcSEcCtD
Riluzole—Pruritus—Methotrexate—germ cell cancer	0.000121	0.000385	CcSEcCtD
Riluzole—Diarrhoea—Methotrexate—germ cell cancer	0.000117	0.000373	CcSEcCtD
Riluzole—Dizziness—Methotrexate—germ cell cancer	0.000113	0.00036	CcSEcCtD
Riluzole—Vomiting—Methotrexate—germ cell cancer	0.000109	0.000346	CcSEcCtD
Riluzole—Rash—Methotrexate—germ cell cancer	0.000108	0.000343	CcSEcCtD
Riluzole—Dermatitis—Methotrexate—germ cell cancer	0.000108	0.000343	CcSEcCtD
Riluzole—Headache—Methotrexate—germ cell cancer	0.000107	0.000341	CcSEcCtD
Riluzole—CYP1A2—Aryl Hydrocarbon Receptor—MYC—germ cell cancer	0.000102	0.00212	CbGpPWpGaD
Riluzole—Nausea—Methotrexate—germ cell cancer	0.000102	0.000323	CcSEcCtD
Riluzole—CYP1A1—Metabolism of lipids and lipoproteins—CRABP1—germ cell cancer	9.65e-05	0.00201	CbGpPWpGaD
Riluzole—CYP1A2—Aryl Hydrocarbon Receptor—HRAS—germ cell cancer	7.98e-05	0.00166	CbGpPWpGaD
Riluzole—ABCG2—Metabolism—SLC2A3—germ cell cancer	7.91e-05	0.00165	CbGpPWpGaD
Riluzole—SLC7A11—Hemostasis—TP53—germ cell cancer	7.84e-05	0.00163	CbGpPWpGaD
Riluzole—ABCG2—Metabolism—SLC22A3—germ cell cancer	7.79e-05	0.00162	CbGpPWpGaD
Riluzole—ABCG2—Transmembrane transport of small molecules—AVP—germ cell cancer	7.79e-05	0.00162	CbGpPWpGaD
Riluzole—SLC7A11—Hemostasis—HRAS—germ cell cancer	7.49e-05	0.00156	CbGpPWpGaD
Riluzole—ABCG2—Metabolism—CRABP1—germ cell cancer	6.35e-05	0.00132	CbGpPWpGaD
Riluzole—SCN5A—Axon guidance—HRAS—germ cell cancer	6.34e-05	0.00132	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism of lipids and lipoproteins—CRABP1—germ cell cancer	6.15e-05	0.00128	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism—SLC2A3—germ cell cancer	5.35e-05	0.00112	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism—SLC22A3—germ cell cancer	5.27e-05	0.0011	CbGpPWpGaD
Riluzole—SCN5A—Developmental Biology—HRAS—germ cell cancer	4.53e-05	0.000943	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism—CRABP1—germ cell cancer	4.3e-05	0.000895	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism—SLC2A3—germ cell cancer	3.41e-05	0.000711	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism—SLC22A3—germ cell cancer	3.36e-05	0.0007	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism—CRABP1—germ cell cancer	2.74e-05	0.000571	CbGpPWpGaD
